Exploratory Analyses of Patient Preferences for Atezolizumab Subcutaneous Versus Intravenous from the IMscin002 Study in Patients with Non-Small Cell Lung Cancer

Authors

Federico Cappuzzo (ORCID: https://orcid.org/0000-0002-6295-6767)
Ki Hyeong Lee (ORCID: https://orcid.org/0000-0002-7830-5950)
Alberto Bustillos (ORCID: https://orcid.org/0000-0002-4409-8113)
Jaroslaw Kolb-Sielecki
Margarita Majem (ORCID: https://orcid.org/0000-0002-9919-7485)
B. Chewaskulyong (ORCID: https://orcid.org/0000-0003-4052-5728)
Sang-We Kim
Xiaoyan Liu (ORCID: https://orcid.org/0000-0002-8276-907X)
Ernesto Korbenfeld (ORCID: https://orcid.org/0000-0001-6343-9991)
Amparo Yovanna Castro Sanchez
Zanete Zvirbule
Luis A. Herráez-Baranda

Institutions

Roche (Switzerland) (CH)
Hospital de Sant Pau (ES)
University of Ulsan (KR)
Riga East University Hospital (LV)
Hospital Británico de Buenos Aires (AR)
Istituti di Ricovero e Cura a Carattere Scientifico (IT)
Olsztyńska Szkoła Wyższa im. Józefa Rusieckiego (PL)
Chungbuk National University Hospital (KR)
Chiang Mai University (TH)

Publication Details

Journal: Oncology and Therapy
Published: 2025-11-26
DOI: https://doi.org/10.1007/s40487-025-00402-x
Primary Topic: Cancer Immunotherapy and Biomarkers
Type: article
Field-Weighted Citation Impact: 0.00

Funders

F. Hoffmann-La Roche

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Exploratory Analyses of Patient Preferences for Atezolizumab Subcutaneous Versus Intravenous from the IMscin002 Study in Patients with Non-Small Cell Lung Cancer

Federico Cappuzzo, Ki Hyeong Lee, Alberto Bustillos, Jaroslaw Kolb-Sielecki et al.

Nov 26, 2025

Oncology and Therapy

Cancer Immunotherapy and Biomarkers

article

Exploratory Analyses of Patient Preferences for Atezolizumab Subcutaneous Versus Intravenous from the IMscin002 Study in Patients with Non-Small Cell Lung Cancer

Federico Cappuzzo, Ki Hyeong Lee, Alberto Bustillos, Jaroslaw Kolb-Sielecki, Margarita Majem, B. Chewaskulyong, Sang-We Kim, Xiaoyan Liu, Ernesto Korbenfeld, Amparo Yovanna Castro Sanchez, Zanete Zvirbule, Luis A. Herráez-Baranda

November 26, 2025article en

Abstract

No abstract available for this paper.

Oncology and TherapyVol. 14(1)

Roche (Switzerland) (CH), Hospital de Sant Pau (ES), University of Ulsan (KR), Riga East University Hospital (LV), Hospital Británico de Buenos Aires (AR), Istituti di Ricovero e Cura a Carattere Scientifico (IT), Olsztyńska Szkoła Wyższa im. Józefa Rusieckiego (PL), Chungbuk National University Hospital (KR), Chiang Mai University (TH)

F. Hoffmann-La Roche

Openalex Percentile: Top 49%

Cancer Immunotherapy and Biomarkers

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.